Heparin-dependent fibroblast growth factor activities: Effects of defined heparin oligosaccharides

European Journal of Cell Biology

Volumn 73, Issue 1, 1997, Pages 71-80

  Zhou, Fan Yu ^a   Kan, Mikio ^a   Owens, Rick T ^a   McKeehan, Wallace L ^a   Thompson, John A ^b   Linhardt, Robert J ^c   Höök, Magnus ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UAB Department of Surgery   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Fibroblast growth factor; Fibroblast growth factor receptor; Heparin; Oligosaccharide

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARIN; OLIGOSACCHARIDE; POLYSACCHARIDE; SODIUM CHLORIDE;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALIA; INSECTA;

EID: 0030994383     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Aviezer, D., E. Levy, M. Safran, C. Svahn, E. Buddecke, A. Schmist, G. David, I. Vlodavsky, A. Yayon: Different structural requirements of heparin and heparan sulfate proteoglycan that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem. 269, 114-121 (1994).
2. Baird, A., D. Schubert, N. Ling, R. Guilemin: Receptor-and heparin-binding domains of basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 85, 2324-2328 (1988).
3. Baird, A., M. Klagsbrun: The fibroblast growth factor family. Cancer Cells 3, 239-243 (1991).
4. Bashkin, P., S. Doctrow, M. Klagsbrun, C. M. Svahn, J. Folkman, I. Vlodavsky: Basic fibroblast growth factor binds subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28, 1737-1743 (1989).
5. Bitter, T., H. Muir: A modified uronic acid carbazole reaction. Anal. Biochem. 4, 330-334 (1962).
6. Burgess, W. H., T. Maciag: The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575-606 (1989).
7. Dionne, C. A., G. Crumley, F. Bellot, J. M. Kaplow, G. Searfoss, M. Ruta, W. H. Burgess, M. Jaye, J. Schlessinger: Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9, 2685-2692 (1990).
8. Faham, S., R. E. Hileman, J. R. Fromm, R. J. Linhardt, D. C. Rees: Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116-1120 (1996).
9. Gospodarowicz, D., J. Cheng: Heparin protects basic and acidic FGFfrom inactivation. J. Cell. Physiol. 128, 475-484 (1986).
10. Gospodarowicz, D.: Isolation and characterization of acidic and basic fibroblast growth factor. Methods Enzymol. 147, 106-119 (1987).
11. Guimond, S., M. Maccarana, B. B. Olwin, U. Lindahl, A. C. Rapraeger: Activating and inhibitory heparin sequences for FGF-2 (basic FGF): distinct requirements for FGF-1, FGF-2 and FGF-4. J. Biol. Chem. 268, 23906-23914 (1993).
12. Höök, M., I. Björk, J. Hopwood, U. Lindahl: Anticoagulant activity of heparin: separation of high-activity and low activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett. 66, 90-93 (1976).
13. Hou, J., M. Kan, K. McKeehan, G. McBride, P. Adams, W. L. McKeehan: Fibroblast growth factor receptors from liver vary in three structural domains. Science 251, 665-668 (1991).
14. Imamura, T., K. Engleka, X. Zhan, Y. Tokita, R. Forough, D. Roeder, A. Jackson, J. Maier, T. Hla, T. Maciag: Recovery of mitogenic activity of a heparin-binding growth factor-1 mutant with a nuclear translocation sequence. Science 249, 1567-1570 (1990).
15. Ishihara, M.: Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. Glycobiology 4, 817-824 (1994).
16. Ishihara, M., P. N. Shaklee, Z. Yang, W. Liang, Z. Wei, R. J. Stack, K. Holme: Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor. Glycobiology 4, 451-458 (1994).
17. Jaye, M., J. Schlessinger, C. A. Dionne: Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta 1135, 185-199 (1992).
18. Kan, M., D. DiSorbo, J. Hou, H. Hishi, P.-E. Masson, W. L. McKeehan: High and low affinity binding of heparin-binding growth factor to a 130 kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell. J. Biol. Chem. 263, 11306-11313 (1988).
19. Kan, M., E. Shi, W. L. McKeehan: Identification and assay of fibroblast growth factor receptors. Methods Enzymol. 198, 158-171 (1991).
20. Kan, M., F. Wang, M. Kan, B. To, J. L. Gabriel, W. L. McKeehan: Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex. J. Biol. Chem. 271, 26143-26148 (1996).
21. Kan, M., F. Wang, J. Xu, J. W. Crabb, J. Hou, W. L. McKeehan: An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259, 1918-1921 (1993).
22. Keegan, K., D. E. Johnson, L. T. Williams, M. J. Hayman: Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc. Natl. Acad. Sci. USA 88, 1095-1099 (1991).
23. Keller, K. M., P. R. Brauer, J. M. Keller: Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 28, 8100-8107 (1989).
24. Klagsbrun, M.: The affinity of fibroblast growth factors (FGFs) for heparin: FGF-heparan sulfate interaction in cells and extracellular matrix. Curr. Opin. Cell Biol. 2, 857-863 (1990).
25. Lin, K. H., S. Y. Cheng: An efficient method to purify active eukaryotic proteins from the inclusion bodies in Escherichia coli. Biotechniques 11, 748-752 (1991).
26. Lindahl, U., G. Bäckström, L. Jansson, A. Hallen: Biosynthesis of heparin. II. Formation of sulfamino groups. J. Biol. Chem. 248, 7234-7241 (1973).
27. Lohse, D. L., R. J. Linhardt: Purification and characterization of heparin lyases from Flavobacterium heparinum. J. Biol. Chem. 267, 24347-24355 (1992).
28. Maccarana, M., B. Casu, U. Lindahl: Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem. 268, 23898-23905 (1993).
29. Mason, I. J.: The ins and outs of fibroblast growth factors. Cell 78, 347-552 (1994).
30. McKeehan, W. L., M. Kan: Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships. Mol. Reproduct. Dev. 39, 69-82 (1994).
31. Ornitz, D. M., A. B. Herr, M. Nilsson, J. Westman, C.-M. Svahn, G. Waksman: FGF binding and FGF receptor activation by synthetic heparan-derived di-and trisaccharides. Science 268, 432-436 (1995).
32. Pantoliano, M. W., R. A. Horlick, B. A. Springer, D. E. Van Dyk, T. Tobery, D. R. Wetmore, J. D. Lear, A. T. Nahapetian, J. D. Bradley, W. P. Sisk: Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 33, 10229-10248 (1994).
33. Partanen, J., T. P. Makela, E. Eerola, J. Korhonen, H. Hirvonen, W. L. Claesson, K. Alitalo: FGFR-4, a novel acidic growth factor receptor with a distinct expression pattern. EMBO J. 10, 1347-1353 (1991).
34. Pervin, A., C. Gallo, K. A. Jamdik, X.-J. Han, R. J. Linhardt: Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology 5, 83-95 (1995).
35. Pervin, A., A. Al-Hakim, R. J. Linhardt: Separation of glycosaminoglycan-derived oligosaccharides by capillary electrophoresis using reverse polarity. Anal. Biochem. 221, 182-188 (1994).
36. Ruta, M., R. Howk, G. Ricca, W. Drohan, M. Zabelshansky, G. Laureys, D. E. Barton, U. Franke, J. Schlessinger, D. Givol: A novel protein-tyrosine kinase gene whose expression is modulated during endothelial cell differentiation. Oncogene 3, 9-15 (1988).
37. Saksela, O., D. Moscatelli, A. Sommer, D. B. Rifkin: Endothelial cell-derived heparan sulfate binds bask fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107, 743-751 (1988).
38. Shi, E., M. Kan, J. Xu, F. Wang, W. L. McKeehan: Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants. Mol. Cell. Biol. 13, 3907-3918 (1993).
39. Shively, J. E., H. E. Conrad: Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 15, 3932-3942 (1976).
40. Spinger, B. A., M. W. Pantoliano, F. A. Barbera, P. L. Gunyuzlu, L. D. Thompson, W. F. Herblin, S. A. Rosenfeld, G. W. Book: Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol Chem. 269, 26879-26884 (1994).
41. Spivak-Kroizman, T., M. A. Lemmon, I. Dikic, J. E. Ladbury, D. Pinchasi, J. Huang, M. Jaye, G. Crumley, J. Schlessinger, I. Lax: Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79, 1015-1024 (1994).
42. Tyrrell, D. J., M. Ishihara, N. Rao, A. Horne, M. C. Kiefer, G. B. Stauber, L. H. Lam, R. J. Stack: Structural and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor. J. Biol. Chem. 268, 4684-4689 (1993).
43. Walker, A., J. E. Turnbull, J. T. Gallagher: Specific heparan sulfate saccharides mediate the activity of bFGF. J. Biol. Chem. 269, 931-935 (1994).
44. Wang, F., M. Kan, G. Yan, J. Xu, W. L. McKeehan: Alternately spliced NH2-terminal immunoglobulin-like loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1. J. Biol. Chem. 270, 10231-10235 (1995).
45. Webb, N. R., C. Madonlet, P. F. Tosi, D. R. Broussard, L. Sneed, C. Hicolau, M. D. Summers: Cell surface expression and purification of human CD4 produced in baculovirus-infected insect cells. Proc. Natl. Acad. Sci. USA 86, 7731-7735 (1989).
46. Xu, J., M. Nakahara, J. W. Crabb, E. Shi, Y. Matuo, M. Fraser, M. Kan, J. Hou, W. L. McKeehan: Expression and immunochemical analysis of rat prostate and human heparin-binding fibroblast grown factor receptor (flg) isoforms. J. Biol. Chem. 267, 17792-17803 (1992).
47. Yayon, A., M. Klagbrun, J. Esko, P. Leder, D. Ornitz: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848 (1991).
48. Zhang, J. D., L. S. Consens, P. J. Barr, S. R. Sprang: Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta. Proc. Natl. Acad. Sci. USA 88, 3446-3450 (1991).
49. Zhou, F.-Y., R. T. Owens, J. Hormonen, M. Jalkanen, M. Höök: Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans? Eur. J. Cell Biol., in press June 1997.
50. Zhu, X., H. Komiya, A. Chirino, S. Faham, G. M. Fox, T. Arakawa, B. T. Hsu, D. C. Rees: Three-dimensional structure of acidic and basic fibroblast growth factors. Science 251, 90-93 (1991).